EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudie

Venoarterial extracorporeal membrane oxygenation versus off-pump lung transplantation: Interim analysis of a prospective, randomized clinical trial

Mauricio A Villavicencio, Sahar A Saddoughi, Philip J Spencer, Matthew Fox, Christian A Bermudez, Bryan A Whitson, Kukbin Choi, Abul Kashem, Kelly M Pennington, Suraj M Yalamuri, Jackie R Reiter, Brian D Lahr und 6 weitere

The Journal of Thoracic and Cardiovascular Surgery · 2026

DOI: 10.1016/j.jtcvs.2025.12.021 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2026. Verfasst von Mauricio A Villavicencio und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn; Transplant Center, Mayo Clinic, Rochester, Minn. Electronic address: Villavicenci…. Hauptthemen laut MEDLINE: Lung Transplantation, Extracorporeal Membrane Oxygenation, Primary Graft Dysfunction. Die Arbeit nennt 18 Literaturangaben. Gefördert von: Mayo Clinic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Primary graft dysfunction (PGD) after lung transplantation (LTx) is associated with increased mortality. Retrospective studies have reported an inconsistent incidence of PGD when comparing intraoperative venoarterial extracorporeal membrane oxygenation (VA ECMO) with off-pump LTx. To address this, we initiated a prospective, randomized trial comparing intraoperative support techniques in LTx. METHODS: This trial compares intraoperative VA ECMO and off-pump LTx outcomes at 90 days. Six centers are currently enrolling. Inclusion criteria include age ≥18 years and bilateral LTx with mean pulmonary artery pressure ≤35 mm Hg. Exclusion criteria include multiorgan transplant, donation after circulatory death, retransplantation, planned postoperative ECMO, previous lung surgery or pleurodesis, and preoperative ECMO or mechanical ventilation. Patients were randomized 1:1 to VA ECMO or off-pump with an intention-to-treat analysis. The primary end point was PGD grade 3 at 48 to 72 hours, and 15 secondary end points were studied. Sample size estimation was determined to be 228 patients to detect a 15% absolute risk reduction in PGD grade 3 at 48 to 72 hours. RESULTS: The interim analysis includes 75 patients. Of these, 44 (58.6%) were randomized to VA ECMO and 31 (41.3%) to off-pump LTx. Four patients (12.9%) crossed over from off-pump to VA ECMO. There was no significant difference between groups in PGD grade 3 at 48 to 72 hours, VA ECMO 6 (13.6%) versus off-pump 6 (19.4%), P = .506. No significant differences were observed in the safety profile and secondary end points. There was significantly more fresh-frozen plasma and platelet transfusion in the VA ECMO group. CONCLUSIONS: In this interim analysis of the Veno-arterIal ECMO Versus Off-Pump Bilateral Orthotopic Lung Transplantation trial, no significant primary end-point difference was noted between VA ECMO and off-pump LTx. Continued enrollment is needed to ensure the study is adequately powered.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung TransplantationExtracorporeal Membrane OxygenationPrimary Graft DysfunctionHumansFemaleMaleProspective StudiesMiddle AgedAdultTreatment OutcomeTime FactorsRisk Factors

Stichwörter der Autor:innen

extracorporeal membrane oxygenationlung transplantationsurgical outcomes

Autor:innen und Institutionen

  • Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn; Transplant Center, Mayo Clinic, Rochester, Minn. Electronic address: Villavicencio.mauricio@mayo.edu.
  • Transplant Center, Mayo Clinic, Rochester, Minn; Division of Thoracic Surgery, Department of Surgery, Mayo Clinic, Rochester, Minn.
  • Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn; Transplant Center, Mayo Clinic, Rochester, Minn.
  • Department of Thoracic and Cardiovascular Surgery, University of Louisville, Louisville, Ky.
  • Division of Cardiac Surgery, The Ohio State University College of Medicine, Columbus, Ohio.
  • Division of Cardiovascular Surgery, Temple University Hospital, Philadelphia, Pa.

Förderung

  • Mayo Clinic

Zitieren

APA

Villavicencio, M. A., Saddoughi, S. A., Spencer, P. J., Fox, M., Bermudez, C. A., Whitson, B. A., Choi, K., Kashem, A., Pennington, K. M., Yalamuri, S. M., Reiter, J. R., Lahr, B. D., Lee, A. T., Leon-Pena, A., Fernandez, R., Krishan, K., Toyoda, Y., & Loor, G. (2026). Venoarterial extracorporeal membrane oxygenation versus off-pump lung transplantation: Interim analysis of a prospective, randomized clinical trial. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2025.12.021

Vancouver

Villavicencio MA, Saddoughi SA, Spencer PJ, Fox M, Bermudez CA, Whitson BA, et al. Venoarterial extracorporeal membrane oxygenation versus off-pump lung transplantation: Interim analysis of a prospective, randomized clinical trial. The Journal of Thoracic and Cardiovascular Surgery. 2026. doi:10.1016/j.jtcvs.2025.12.021

BibTeX
@article{Villavicencio2026,
  author = {Villavicencio, Mauricio A and Saddoughi, Sahar A and Spencer, Philip J and Fox, Matthew and Bermudez, Christian A and Whitson, Bryan A and Choi, Kukbin and Kashem, Abul and Pennington, Kelly M and Yalamuri, Suraj M and Reiter, Jackie R and Lahr, Brian D and Lee, Alexander T and Leon-Pena, Andres and Fernandez, Ramiro and Krishan, Kewal and Toyoda, Yoshiya and Loor, Gabriel},
  title = {Venoarterial extracorporeal membrane oxygenation versus off-pump lung transplantation: Interim analysis of a prospective, randomized clinical trial},
  journal = {The Journal of Thoracic and Cardiovascular Surgery},
  year = {2026},
  doi = {10.1016/j.jtcvs.2025.12.021}
}
Kostenlos starten →